Wedelolactone induces pyroptosis to suppress retinoblastoma by inhibiting the Nrf2/Keap1 signaling pathway
Authors:
Open Access
- 29 August 2025
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 42 (10) , 1-11
Abstract
Background Retinoblastoma is an intraocular malignancy with limited therapeutic options, imposing a severe health burden on young patients. Wedelolactone (WDL), a natural product from E. prostrata, possesses an anti-retinoblastoma activity, with the underlying regulatory mechanism remaining unknown. Methods Retinoblastoma cell lines and xenograft nude mouse models were treated with WDL and RTA-408, an agonist for nuclear factor-erythroid 2-related factor 2 (Nrf2). Western blotting was conducted to determine the protein expression levels of kelch-like ECH-associated protein 1 (Keap1) and Nrf2. We performed the cell counting kit-8 assay, the 5-ethynyl-2-deoxyuridine staining, and flow cytometry to detect cell viability, proliferation, and apoptosis, respectively. The tumor progression in vivo was evaluated via the measurement of volume, weight, and proliferation levels of solid tumors. Monosodium urate crystal was applied to activate pyroptosis which was assessed by the expression detection of pyroptosis-related indicators. Results WDL treatment elevated the expression of Keap1 and reduced the level of Nrf2. RTA-408 suppressed WDL-induced pyroptosis of retinoblastoma cells and reversed the effect of WDL on inhibiting retinoblastoma cell proliferation, promoting tumor cell apoptosis, and repressing the growth of solid tumors of the xenograft models. In addition, monosodium urate-induced pyroptosis partially restored the anti-retinoblastoma effect of WDL impaired by RTA-408. Conclusion WDL triggers pyroptosis by inhibiting the Nrf2/Keap1 signaling pathway to exert anti-retinoblastoma effects.Keywords
Funding Information
- Guangzhou Women and Children's Medical Center Doctoral Initiation Fund (2023BS026, 2023BS026, 2023BS026, 2023BS026, 2023BS026, 2023BS026, 2023BS026)
- The Guangzhou Science and Technology Program Project (202201020606, 202201020606, 202201020606, 202201020606, 202201020606, 202201020606, 202201020606)
This publication has 45 references indexed in Scilit:
- Triptolide attenuates cardiac remodeling by inhibiting pyroptosis and EndMT via modulating USP14/Keap1/Nrf2 pathwayHeliyon, 2024
- Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathwayNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Eriodictyol regulated ferroptosis, mitochondrial dysfunction, and cell viability via Nrf2/HO‐1/NQO1 signaling pathway in ovarian cancer cellsJournal of Biochemical and Molecular Toxicology, 2023
- Wedelolactone: A molecule of interestsFitoterapia, 2022
- Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson’s disease: A reviewBiomedicine & Pharmacotherapy, 2022
- Xiaojianzhong decoction attenuates gastric mucosal injury by activating the p62/Keap1/Nrf2 signaling pathway to inhibit ferroptosisBiomedicine & Pharmacotherapy, 2022
- Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generationInternational Immunopharmacology, 2022
- Anti-inflammatory effect of wedelolactone on DSS induced colitis in rats: IL-6/STAT3 signaling pathwayJournal of Ayurveda and Integrative Medicine, 2022
- Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathwayInternational Ophthalmology, 2020
- Wedelolactone protects human bronchial epithelial cell injury against cigarette smoke extract-induced oxidant stress and inflammation responses through Nrf2 pathwayInternational Immunopharmacology, 2015